Elevation of c-abl-mRNA in human leukemic B lymphoblasts

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• The c-abl gene plays a crucial role in cell growth and differentiation.
• Aberrant c-abl expression is implicated in various leukemias, particularly chronic myeloid leukemia (CML).
• Understanding c-abl transcript variations is key to deciphering leukemia pathogenesis.

Purpose of the Study:

• To analyze v-abl-homologous transcripts in leukemia patients.
• To investigate the relationship between c-abl expression levels and specific leukemia types.
• To determine if gross gene rearrangement or the Philadelphia chromosome is consistently associated with increased c-abl transcription.

Main Methods:

• Analysis of v-abl-homologous transcripts in peripheral blood leukocytes from 20 leukemia patients using mRNA analysis.
• Detection and size characterization of abl-homologous transcripts (5-kb, 2-kb, 10-kb).
• Genomic DNA analysis and karyotypic analysis for chromosomal abnormalities.

Main Results:

• A 5-kb species was the major abl-mRNA in most patients.
• Elevated 5-kb transcripts and detectable 2- and 10-kb species were found in two patients: one with Philadelphia chromosome-positive CML in lymphoid blast crisis, and one with childhood Burkitt-type B-lymphoblastic leukemia.
• No gross gene rearrangement or Philadelphia chromosome abnormality was consistently linked to increased c-abl transcription.

Conclusions:

• Increased c-abl transcription is not solely dependent on the Philadelphia chromosome or gross gene rearrangement.
• High c-abl mRNA levels may be associated with specific cell types, such as early lymphoid blasts.
• Failure to down-regulate c-abl could be a contributing factor in the development of pre- or early B-lymphoid leukemias.